Additionally, CD155 is over-expressed on cancer cells in human malignancies including colon cancer (26), lung adenocarcinoma (27), melanoma (28), pancreatic cancer (29), glioblastoma (30) and hepatocellular carcinoma (31). Here, PVR is linked to hepatocellular carcinoma.